NIVolumab in Subjects With Recurrent or Metastatic Platinum-refrACTORy SCCHN
Clinical trial NCT05802290 · COMPLETED
Trial details
- NCT number
- NCT05802290
- Sponsor
- Gruppo Oncologico del Nord-Ovest
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-27
- Primary completion
- 2020-03-26
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.